Effectiveness and Tolerability of Zavegepant for Acute Migraine Treatment Among Those Using CGRP Targeting Preventive Medications

Abroad (travel likely)RecruitingPHASE4

Conditions

Migraine

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Mayo Clinic in Arizona, Phoenix, Arizona, United States
Contact: Study coordinator (Michael R Leonard) · Leonard.Michael@Mayo.edu · 480-342-2908
Contact: Study coordinator (Dani SMith) · Smith.Dani@mayo.edu · 480-342-6524
Contact: Principal Investigator (Todd J Schwedt, MD)

Study leads

Todd Schwedt, MD
Principal Investigator
Mayo Clinic

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine

Acute Treatment of Migraine

Abroad (travel likely)RecruitingPHASE1

Little Rock, United States · Washington D.C., United States

A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine

Acute Treatment of Migraine

Abroad (travel likely)RecruitingPHASE4

Canoga Park, United States · Boca Raton, United States

Evaluation of Efficacy and Safety of Topical Cannabidiol (Canvert-M Produced by Alasht Pharmed co. Iran) in the Treatment of Migraine Attacks

Migraine Disorders

Abroad (travel likely)RecruitingPHASE4

Tehran, Iran

A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years

Chronic Migraine

Abroad (travel likely)RecruitingPHASE3

Huntsville, United States · Fayetteville, United States